AHIA Events and Conferences

AHIA National Conference 2005 (8-10 November 2005)
Venue: Sofitel Melbourne

The Pathway to Sustainable Affordability

Conference Details

  • Conference Brochure   (1.33 MB PDF)

    The AHIA 2005 Conference considered the future of Health Insurance in Australia and the increasing challenges faced by health funds to provide an affordable and quality product to the consumer. Issues that were addressed included:

  • strategies for change for addressing an ageing population
  • chronic diseases
  • growing membership
  • the impact of medical technology and innovation on costs

    Conference Presentations

    SESSION
    TOPIC
    SPEAKER
    OUTLINE
    PRESENTATION
    DAY ONE
    1
    Sustainable affordability in health care financing & delivery
    Bernard J Tyson, Senior Vice President, Brand Strategy and Management, Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals
    • Sustainable affordability in health care financing and delivery from the perspective of Kaiser Permanente
    • The challenges to sustainable health care financing and delivery
    • Achievement and current challenges of Kaiser Permanente
    • Private sector solutions to affordable health care delivery
    • Improving the efficiency and quality of health care
    • Developing patient-centred care
    • Implications for private health insurance in Australia
    2
    Sustainable affordability - Australian and New Zealand experiences with Private Health Insurance
    Professor Ian Harper, Executive Director, Melbourne Business School
    • The Benefits of Private Health Insurance
    • Effect of the rebate on public hospital waiting lists
    • Private health insurance and sustainable affordability in Australia
    Dr Ian McPherson, Chief Executive Officer, Southern Cross Healthcare, New Zealand
    • Update on the role of private health insurance in New Zealand
    • The challenge of sustainability for Southern Cross Health Fund
    • Private health insurance innovations
    • Medical savings accounts
    • Implications for private health insurance in Australia
    3
    Chronically ill patients - Health fund approaches to coordination of care and self management
    Bruce Levy, Group Manager, Health Services, Medibank Private

    Chronic Care Initiatives at Medibank Private

    • Medibank Private's approach to chronic care
    Not Available
    Virginia Haggar, Director-Education, International Diabetes Institute
    • A provider perspective
    • The results of Medibank-on-Track Program - diabetes management pilot
    Not Available
    Keith Finney, General Manager, Provider & Procurement, BUPA Australia Health
    • BUPA's approach to chronic care
    • A clinician's perspective
    • Patient perspective: how AuseMed has helped
    TBA
    4
    Responses to providing better quality health care at an affordable cost; The potential for more effective use of data DR Martin Van Der Weyden, Editor, The Medical Journal of Australia

    Safety in Australian Healthcare: who cares?

    • The safety of Australian Health Care - QAHCS Study, sentinel events, incidents and scandals
    • The need for reform
    • Clinical workforce shortages and health care financing challenges
    • Role of Australian Council for Quality & Safety in Health Care
    • Urgent areas for action
    • Implications for private health insurance
    Not Available
    The Hon DR Michael Wooldridge
    • The mixed public/private Australian health system
    • Overview of Australian health and health service indicators and international comparative data
    • Using data to improve health services
    • Barriers to linking data and establishing effective databases in Australia
    Not Available
    Professor Peter Collignon, Director, Infectious Diseases Unit, The Canberra Hospital (Presentation delivered by Professor Lindsay Grayson, Infectious Diseases Department, Austin Health and Department of Medicine, University of Melbourne)
    • The extent of health care associated infections in Australian hospitals
    • Staphylococcus aureus and MRSA
    • Trends and outlook
    • Clinical presentation of patients
    • High risk patients
    • National strategies for prevention
    • Data collection and monitoring
    • Impact on health care quality, patient outcomes and costs
    DAY TWO
    5
    An ageing Australia: Implications for health expenditure and private health insurance Bernard Salt, Partner, KPMG
    • Demographic trends and an ageing Australia
    • Current outlook
    • Health expenditure and health insurance implications
    Rhonda Parker, Chief Executive, Positive Ageing Foundation of Australia
    • Research findings on the impact of ageing
    • Trends
    • Healthy ageing
    • Needs of mature people
    • Services and programs to promote successful ageing
    • Implications for health insurers

     

    Professor Allan McLean, Director, National Ageing Research Institute
    • The biology of ageing
    • Cause, prevention and cure of disease
    • Consequences of ageing and its social accompaniments
    • Lessons for health insurers
    6
    Musculoskeletal disease and injury, treatment and rehabilitation Professor Stephen Graves, Director, Australian Orthopaedic Assoc. National Joint Replacement Registry The Scope of Musculoskeletal Disease - Treatment and Costs
    • The scope of musculoskeletal disease
    • Incidence, prevalence, extent of the disease
    • Trends and implications for treatment and coverage
    • Cost implications
    • Patient management
    • Joint replacement
    • Improving health outcomes and reducing cost.
    DR Marlene Fransen, Senior Research Fellow, Injury Prevention and Trauma Care, The George Institute for International Health, University of Sydney
    • Extent of knee replacement operations in Australia
    • Trends
    • Demographics
    • Post-operative recovery and rehabilitation outcomes
    • Cost-effectiveness and scientific evidence
    • Implications for private health insurance

     

    7
    Can we keep pharmaceutical costs affordable and new medicines viable? Professor Andrew Wilson, Chair, Economic Committee, Pharmaceutical Benefits Advisory Committee, DoHA
    • Overview of the Pharmaceutical Benefits Scheme
    • Special Access and High Cost Drugs
    • Current coverage and expenditure
    • Future trends
    • Impact of new technologies and high cost drugs
    • Drugs in the pipeline
    • Role of PBAC
    • Evaluation methods used in PBAC decision-making
    • Implications for private health insurance
    8
    The ACCC view of key competition issues impacting on the Private Health Sector John Martin, Commissioner, Australian Competition and Consumer Commission
    • The ACCC approach to approval of recent large merger proposals, such as Ramsay/Affinity
    • Update on ACCC's monitoring of anti-competitive practices impacting on private health insurance
    • ACCC view of sustainable affordability and whether hospital mergers and takeovers result in lower prices for consumers
    • Competition, health funds and the privatisation of Medibank Private
    • Future outlook for the private health sector from the ACCC viewpoint